Mead MD - Search Results

1

Davis AS, Viera AJ, Mead MD. Davis AS, et al. Among authors: mead md. Am Fam Physician. 2014 May 1;89(9):731-8. Am Fam Physician. 2014. PMID: 24784336 Free article. Review.

2

Measurable residual disease in hematopoietic stem cell transplantation-eligible patients with acute myeloid leukemia: clinical significance and promising therapeutic strategies.

Gaut D, Mead M. Gaut D, et al. Leuk Lymphoma. 2021 Jan;62(1):8-31. doi: 10.1080/10428194.2020.1827251. Epub 2020 Nov 2. Leuk Lymphoma. 2021. PMID: 33138674 Review.

3

Cardiac Complications in the Adult Bone Marrow Transplant Patient.

Tuzovic M, Mead M, Young PA, Schiller G, Yang EH. Tuzovic M, et al. Curr Oncol Rep. 2019 Mar 2;21(3):28. doi: 10.1007/s11912-019-0774-6. Curr Oncol Rep. 2019. PMID: 30826891 Review.

4

BCOR regulates myeloid cell proliferation and differentiation.

Cao Q, Gearhart MD, Gery S, Shojaee S, Yang H, Sun H, Lin DC, Bai JW, Mead M, Zhao Z, Chen Q, Chien WW, Alkan S, Alpermann T, Haferlach T, Müschen M, Bardwell VJ, Koeffler HP. Cao Q, et al. Among authors: mead m. Leukemia. 2016 May;30(5):1155-65. doi: 10.1038/leu.2016.2. Epub 2016 Feb 5. Leukemia. 2016. PMID: 26847029 Free PMC article.

5

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients.

Mead M, Cederleuf H, Björklund M, Wang X, Relander T, Jerkeman M, Gaut D, Larson S, Ellin F. Mead M, et al. Blood Adv. 2022 Apr 12;6(7):2120-2128. doi: 10.1182/bloodadvances.2021004269. Blood Adv. 2022. PMID: 34570186 Free PMC article.

6

Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.

Ghafouri S, Fenerty K, Schiller G, de Vos S, Eradat H, Timmerman J, Larson S, Mead M. Ghafouri S, et al. Clin Lymphoma Myeloma Leuk. 2021 Dec;21(12):861-872. doi: 10.1016/j.clml.2021.07.002. Epub 2021 Jul 19. Clin Lymphoma Myeloma Leuk. 2021. PMID: 34389271 Free article.

7

Axicabtagene Ciloleucel CAR T-cell therapy for relapsed/refractory secondary CNS non-Hodgkin lymphoma: comparable outcomes and toxicities, but shorter remissions may warrant alternative consolidative strategies?

Ghafouri S, Timmerman J, Larson S, Mead MD. Ghafouri S, et al. Among authors: mead md. Bone Marrow Transplant. 2021 Apr;56(4):974-977. doi: 10.1038/s41409-020-01099-4. Epub 2020 Nov 10. Bone Marrow Transplant. 2021. PMID: 33168933 Free PMC article. No abstract available.

8

Triple-negative breast cancer: advancements in characterization and treatment approach.

Hurvitz S, Mead M. Hurvitz S, et al. Curr Opin Obstet Gynecol. 2016 Feb;28(1):59-69. doi: 10.1097/GCO.0000000000000239. Curr Opin Obstet Gynecol. 2016. PMID: 26694831 Review.

9

Immune tolerance induction through haematopoietic chimerism after kidney donation.

Nassiri N, Lum E, Mead MD, Raldow AC, Kogut N, Veale JL. Nassiri N, et al. Among authors: mead md. Lancet. 2022 Aug 6;400(10350):e2. doi: 10.1016/S0140-6736(22)00914-X. Lancet. 2022. PMID: 35934008 No abstract available.

10

The role of transplantation in Hodgkin lymphoma.

Maranzano M, Mead M. Maranzano M, et al. Front Oncol. 2023 Jan 26;12:1054314. doi: 10.3389/fonc.2022.1054314. eCollection 2022. Front Oncol. 2023. PMID: 36776370 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page